IM Cannabis IMCC
NASDAQ IMCC
$0.11 +0.00 (+4.23%)
As of: Aug 20, 2026 · 3:49 PM EDT

IM Cannabis (IMCC) Net Margin (2020 - 2026)

IM Cannabis (IMCC) posted quarterly Net Margin of 28.42% for Q1 2026, down 2982.0% year-over-year from 0.99% in Q1 2025, and up 70.29% quarter-over-quarter from 95.66% in Q4 2025.

IM Cannabis (IMCC) Net Margin (2020 - 2026) Analysis & Trends

IM Cannabis' Net Margin history runs 7 years deep, the most recent figure standing at 28.42% for Q1 2026.

  • In Q1 2026, Net Margin fell 2982.0% year-over-year to 28.42%; the TTM figure through Mar 2026 stood at 30.05% (up 1864.0% YoY), while the FY2025 annual figure was 20.68%, down 109.0% from the prior year.
  • Net Margin for Q1 2026 stood at 28.42%, up from 95.66% in the prior quarter.
  • The five-year high for Net Margin was 26.36% in Q3 2025, with the low at 872.57% in Q3 2022.
  • The 5-year median for Net Margin is 28.42% (2026), against an average of 91.96%.
  • The sharpest annual moves came in 2022 and 2023: Net Margin plunged 97466 bps in 2022, then surged 88984 bps in 2023.
  • IM Cannabis' Net Margin stood at 146.84% in 2022, then decreased by 12 bps to 164.54% in 2023, then advanced by 8 bps to 151.17% in 2024, then surged by 37 bps to 95.66% in 2025, then surged by 70 bps to 28.42% in 2026.
  • Business Quant data shows IMCC's Net Margin at 28.42% in Q1 2026, 95.66% in Q4 2025, and 26.36% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn -13.91%
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn 42.51%
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 IM Cannabis 537,472.00 -631,498.17 1.09 Mn -57.46%

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.46%
Mar 31, 2026 -28.42%
Dec 31, 2025 -95.66%
Sep 30, 2025 26.36%
Jun 30, 2025 -12.61%
Mar 31, 2025 1.40%
Dec 31, 2024 -151.17%
Sep 30, 2024 -6.64%
Jun 30, 2024 -38.12%
Mar 31, 2024 -49.90%
Dec 31, 2023 -164.54%
Sep 30, 2023 17.27%
Jun 30, 2023 0.00%
Mar 31, 2023 -7.17%
Dec 31, 2022 -146.84%
Sep 30, 2022 -872.57%
Jun 30, 2022 0.00%
Mar 31, 2022 -34.62%
Dec 31, 2021 -128.86%
Sep 30, 2021 102.09%